Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)
Authors:
- V. PengoVPV. Pengo
- G. DenasGDG. Denas
- P. GreselePGP. Gresele
- F. MarongiuFMF. Marongiu
- F. VeschiFVF. Veschi
- E. De CandiaECE. De Candia
- 1 August 2010
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 126 (2) , 150-153
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Biological and Clinical Relevance of Anti‐Prothrombin AntibodiesAnnals of the New York Academy of Sciences, 2007
- Anti‐prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15‐year longitudinal studyJournal of Thrombosis and Haemostasis, 2007
- Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samplesJournal of Thrombosis and Haemostasis, 2007
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosisJournal of Thrombosis and Haemostasis, 2005
- IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosisBlood, 2005
- Proposals for the measurement of anti‐β2‐glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid AntibodiesJournal of Thrombosis and Haemostasis, 2004
- Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodiesThrombosis Research, 2004
- Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeBlood, 2003
- Antibodies to Phospholipid-Binding Plasma Proteins and Occurrence of Thrombosis in Patients with Systemic Lupus ErythematosusClinical Immunology and Immunopathology, 1996